By inhibiting these two enzymes, the cholinergic transmission in the brain can be enhanced, thereby relieving the symptoms of AD, such as memory loss and mortality risk, making cholinesterase inhibitors the sole approved treatment for AD and neurodegenerative dementia [10,16,43]. Here, BCHE is linked to Alzheimer disease.